Cargando…
A Disintegrin and Metalloprotease‐22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway
BACKGROUND: Severe cardiac hypertrophy can lead to cardiac remodeling and even heart failure in the end, which is a leading cause of cardiovascular disease–related mortality worldwide. A disintegrin and metalloprotease‐22 (ADAM22), a member of the transmembrane and secreted metalloendopeptidase fami...
Autores principales: | Ren, Lingyun, Wu, Chuangyan, Yang, Kai, Chen, Shanshan, Ye, Ping, Wu, Jie, Zhang, Anchen, Huang, Xiaofan, Wang, Ke, Deng, Peng, Ding, Xiangchao, Chen, Manhua, Xia, Jiahong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850139/ https://www.ncbi.nlm.nih.gov/pubmed/29358191 http://dx.doi.org/10.1161/JAHA.117.005696 |
Ejemplares similares
-
Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242
por: Wu, Chuangyan, et al.
Publicado: (2017) -
A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions
por: Giebeler, Nives, et al.
Publicado: (2016) -
A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems
por: Xu, Jiaxi, et al.
Publicado: (2016) -
A Disintegrin and Metalloproteases (ADAMs): Activation, Regulation and Mechanisms of Catalysis
por: Maretzky, Thorsten
Publicado: (2021) -
Effect of type 2 diabetes on A disintegrin and metalloprotease 10
por: Lam, Sum, et al.
Publicado: (2022)